First human tests for new drug formulation
NCT ID NCT07206043
Summary
This study tested a new, more concentrated version of an experimental drug called RPH-104 in 130 healthy volunteers. The main goal was to see how the drug moves through the body, if it's safe, and if it causes an immune reaction when given as a single shot under the skin or into a vein. Researchers compared different doses and injection methods to gather basic safety data for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Llc "Research Lab"
Moscow, 127521, Russia
Conditions
Explore the condition pages connected to this study.